From pharmAlliance

Introducing PharmAlliance International Labs Private Limited’s Ceftriaxone Sodium Vial Range: Pioneering Antibiotic Therapy

Introducing PharmAlliance International Labs Private Limited’s Ceftriaxone Sodium Vial Range: Pioneering Antibiotic Therapy

Spread the love

Introducing PharmAlliance International Labs Private Limited’s Ceftriaxone Sodium Vial Range: Pioneering Antibiotic Therapy

Welcome to PharmAlliance International Labs Private Limited, where innovation and excellence converge to redefine healthcare standards globally. Our Ceftriaxone Sodium Vial Range stands as a testament to our unwavering commitment to quality, efficacy, and patient-centric care, offering a potent antibiotic solution for a myriad of bacterial infections.

Understanding Ceftriaxone Sodium

PharmAlliance Ceftriaxone Sodium Range, a third-generation cephalosporin antibiotic, is renowned for its broad-spectrum activity against both Gram-positive and Gram-negative bacteria. This versatile antibiotic plays a pivotal role in combating a wide array of infectious diseases, offering a lifeline to patients battling bacterial infections worldwide.

Formulations and Strengths

PharmAlliance Ceftriaxone Sodium Vial Range is available in a variety of strengths to accommodate diverse patient needs and treatment protocols. Our vials contain sterile powder for reconstitution, ensuring flexibility and convenience in dosing administration, and are available in:

  • 250mg
  • 500mg
  • 1000mg (1g)
  • 2000mg (2g)

Indications and Therapeutic Applications

Ceftriaxone is indicated for an extensive range of bacterial infections, including but not limited to:

  • Lower respiratory tract infections such as pneumonia and bronchitis
  • Urinary tract infections encompassing cystitis and pyelonephritis
  • Skin and soft tissue infections, addressing conditions like cellulitis and wound infections
  • Intra-abdominal infections, including peritonitis and cholecystitis
  • Bone and joint infections, combating osteomyelitis effectively
  • Meningitis, providing a crucial therapeutic intervention
  • Gonorrhea and pelvic inflammatory disease (PID), offering a reliable treatment option

Pharmacokinetics Insights

  • Absorption: Administered parenterally, Ceftriaxone achieves rapid and extensive plasma concentrations post intramuscular or intravenous injection.
  • Distribution: The drug exhibits widespread distribution into various bodily tissues and fluids, including but not limited to the lungs, kidneys, liver, and cerebrospinal fluid.
  • Metabolism: Ceftriaxone undergoes minimal hepatic metabolism, with a significant proportion excreted unchanged in the urine, ensuring potent therapeutic activity.

PharmAlliance International Labs Private Limited—Your trusted partner in surgical excellence.

Contact Us Now:

Gallery

From Product collection

Pharmalliance.pk© 2025. All rights reserved. Terms of Use and Privacy Policy

auto undefined